Resection of esophageal, gastric, duodenal and colorectal neoplasias by ESD – Learning curve in a prevalence-based unsupervised western setting: a retrospective, multicentric trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025012

Enrollment

480

Registered

2021-04-09

Start date

2021-04-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign neoplasm esophagus, stomach, duodenum, colon or rectum. Malignant neoplasm esophagus, stomach, duodenum, colon and rectum.

Interventions

Group 1: Resection in ESD technique (Endoscopic submucosal dissection)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Esophageal, gastric, duodenal and colorectal neoplasias, that were resected by ESD from 4 different operators (Prof. Dr. S. Faiss, Prof. Dr. F.-L. Dumoulin, Prof. Dr. H.-P. Allgaier, Dr. I. Steinbrück) since 2007 and belong to the first 120 ESD-procedures performed by every single operator.

Exclusion criteria

Exclusion criteria: Neoplasias that were treated before endoscopically or recurrent neoplasias

Design outcomes

Primary

Measure	Time frame
rate of en bloc resection, rate of R0 resection, resection speed	—

Secondary

Measure	Time frame
rate of technical success, rate of conversion to EMR, rate of relevant bleedings, perforation rate, complication rate (rate of relevant bleedings+perforation rate), rate of surgery due to complication, procedure time, rate of curative resection, rate of biological curative resection, recurrence rate	—

Countries

Germany

Contacts

Public ContactIngo Steinbrück

Ev. Diakoniekrankenhaus Freiburg

ingo.steinbrueck@diak-fr.de0761130193355

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026